68 related articles for article (PubMed ID: 12023576)
1. Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype.
Petitjean B; Jardin F; Joly B; Martin-Garcia N; Tilly H; Picquenot JM; Brière J; Danel C; Mehaut S; Abd-Al-Samad I; Copie-Bergman C; Delfau-Larue MH; Gaulard P
Am J Surg Pathol; 2002 Jun; 26(6):724-32. PubMed ID: 12023576
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of unique cell lines derived from pyothorax-associated lymphoma which develops in long-standing pyothorax and is strongly associated with Epstein-Barr virus infection.
Takakuwa T; Luo WJ; Ham MF; Mizuki M; Iuchi K; Aozasa K
Cancer Sci; 2003 Oct; 94(10):858-63. PubMed ID: 14556658
[TBL] [Abstract][Full Text] [Related]
3. Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation.
Nishiu M; Tomita Y; Nakatsuka S; Takakuwa T; Iizuka N; Hoshida Y; Ikeda J; Iuchi K; Yanagawa R; Nakamura Y; Aozasa K
Cancer Sci; 2004 Oct; 95(10):828-34. PubMed ID: 15504251
[TBL] [Abstract][Full Text] [Related]
4. Mapping T cell landscapes in B cell lymphomas.
Küppers R
Nat Cell Biol; 2024 Mar; 26(3):323-324. PubMed ID: 38379050
[No Abstract] [Full Text] [Related]
5. Epstein-Barr virus-negative diffuse large B cell lymphoma with aberrant expression of CD3 and other T cell-associated antigens: report of three cases with a review of the literature.
Wu B; Vallangeon B; Galeotti J; Sebastian S; Rehder C; Wang E
Ann Hematol; 2016 Oct; 95(10):1671-83. PubMed ID: 27431583
[TBL] [Abstract][Full Text] [Related]
6. Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.
Di Napoli A; Soma L; Quintanilla-Martinez L; de Leval L; Leoncini L; Zamò A; Ng SB; Ondrejka SL; Climent F; Wotherspoon A; Dirnhofer S
Virchows Arch; 2023 Sep; 483(3):299-316. PubMed ID: 37555981
[TBL] [Abstract][Full Text] [Related]
7. Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts.
Kurz KS; Ott M; Kalmbach S; Steinlein S; Kalla C; Horn H; Ott G; Staiger AM
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190213
[TBL] [Abstract][Full Text] [Related]
8. EBV-positive pyothorax-associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3.
Higuchi T; Hashida Y; Matsuo K; Kitahata K; Ujihara T; Murakami I; Nakayama T; Daibata M
Cancer Sci; 2023 Jun; 114(6):2622-2633. PubMed ID: 36898851
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.
Gisriel SD; Yuan J; Braunberger RC; Maracaja DLV; Chen X; Wu X; McCracken J; Chen M; Xie Y; Brown LE; Li P; Zhou Y; Sethi T; McHenry A; Hauser RG; Paulson N; Tang H; Hsi ED; Wang E; Zhang QY; Young KH; Xu ML; Pan Z
Mod Pathol; 2022 Oct; 35(10):1411-1422. PubMed ID: 35562413
[TBL] [Abstract][Full Text] [Related]
10. KSHV/HHV8-mediated hematologic diseases.
Cesarman E; Chadburn A; Rubinstein PG
Blood; 2022 Feb; 139(7):1013-1025. PubMed ID: 34479367
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Acquisition of T-cell Associated Markers in Plasma Cell Neoplasms: An Aggressive Disease with Extramedullary Involvement and Very Short Survival.
Soliman DSA; El Sabah H; Ganwo I; Amer A; Taha RY; Szabados L; Eldean MS; Al-Sabbagh A; Ibrahim F
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021043. PubMed ID: 34276912
[TBL] [Abstract][Full Text] [Related]
12. Virus-Driven Carcinogenesis.
Hatano Y; Ideta T; Hirata A; Hatano K; Tomita H; Okada H; Shimizu M; Tanaka T; Hara A
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071792
[TBL] [Abstract][Full Text] [Related]
13. High-Grade Epstein-Barr Virus-Negative Biphenotypic Lymphoma with Expression of B- and T-Cell Markers and Leukemia Presentation: Case Report and Literature Review.
Kohla S; Ibrahim FA; Mudawi D; Akiki S; Soliman D; Al-Sabbagh A; Youssef RRH; Yassin MA
Case Rep Oncol; 2020; 13(3):1215-1226. PubMed ID: 33173488
[TBL] [Abstract][Full Text] [Related]
14. EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.
Dojcinov SD; Fend F; Quintanilla-Martinez L
Pathogens; 2018 Mar; 7(1):. PubMed ID: 29518976
[TBL] [Abstract][Full Text] [Related]
15. CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall.
Pan Z; Chen M; Zhang Q; Wang E; Yin L; Xu Y; Huang Q; Yuan Y; Zhang X; Zheng G; Yuan J
Mod Pathol; 2018 May; 31(5):718-731. PubMed ID: 29327711
[TBL] [Abstract][Full Text] [Related]
16. EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.
Natkunam Y; Goodlad JR; Chadburn A; de Jong D; Gratzinger D; Chan JK; Said J; Jaffe ES
Am J Clin Pathol; 2017 Feb; 147(2):129-152. PubMed ID: 28395107
[TBL] [Abstract][Full Text] [Related]
17. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
18. The histological classification of diffuse large B-cell lymphomas.
Xie Y; Pittaluga S; Jaffe ES
Semin Hematol; 2015 Apr; 52(2):57-66. PubMed ID: 25805585
[TBL] [Abstract][Full Text] [Related]
19. EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.
Ok CY; Li L; Young KH
Exp Mol Med; 2015 Jan; 47(1):e132. PubMed ID: 25613729
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
